Signal: Illumina to divest Grail, ending years-long legal battle
Both the European Commission and the US' Federal Trade Commission have taken issue with Illumina’s reacquisition of Grail.
19 December 2023
19 December 2023
Both the European Commission and the US' Federal Trade Commission have taken issue with Illumina’s reacquisition of Grail.
The transaction is expected to be completed in the first quarter of next year.
The companies will prioritise challenging drug targets across multiple therapy areas, leveraging Anagenex’s AI platform.
The company says that the test can identify the bacteria present in 80% of gastric cancers and lessen reliance on antibiotics.
The system includes a series of removable devices that are arranged in small increments of movement.
The GRIP biosensor transmits data wirelessly to the standard cell phone or other mobile device for display.
Stork is provided as a non-medical device for general health and wellness purposes at retailers across the US.
The NeuroSite Coil placement, compatible with legacy and new NeuroStar systems, will be available in Q1 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
A comprehensive outlook for the leading players across the TMT industry, based on the key themes set to transform the industry landscape over the next two years. You will not find a better guide to technology in 2024.
Give your business an edge with our leading industry insights.